CN104491745A - Traditional Chinese medicine for treating injury of osteoarticular and soft tissue and application of traditional Chinese medicine - Google Patents
Traditional Chinese medicine for treating injury of osteoarticular and soft tissue and application of traditional Chinese medicine Download PDFInfo
- Publication number
- CN104491745A CN104491745A CN201510003740.5A CN201510003740A CN104491745A CN 104491745 A CN104491745 A CN 104491745A CN 201510003740 A CN201510003740 A CN 201510003740A CN 104491745 A CN104491745 A CN 104491745A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- traditional chinese
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Abstract
The invention relates to a traditional Chinese medicine for treating injury of osteoarticular and soft tissue. The traditional Chinese medicine is mainly prepared from the following raw materials: radix clematidis, drynaria rhizome, kadsura pepper stem, radix curcumae, lycopodium clavatum, root of kudzu vine, teasel root, cynanchum paniculatum, ephedra, divaricate saposhnikovia root, cassia twig, abrus cantoniensis hance, radix trichosanthis, semen brassicae, red flower, golden cypress, ligusticum wallichii, Chinese angelica and dried rehamnnia root. The invention further provides an application of the traditional Chinese medicine. The traditional Chinese medicine has a remarkable effect in relieving swelling and pains, is convenient to use, consistent with the theory of the traditional Chinese medicine, remarkable in clinical curative effect, free of bad reaction and worthy of being widely popularized.
Description
Technical field
The present invention relates to technical field, specifically, is a kind of Chinese medicine and application thereof for the treatment of osteoarthrosis and soft tissue injury.
Background technology
Along with mechanical industry, transportation and building industry developing rapidly in modern society, wound is becoming large public hazards of harm public health, and degree of injury becomes heavy, complicated, dead, disability rate obviously increases.Osteoarticular injury is a kind of comparatively serious wound, and how it is caused by powerful external force, has become the lethal one of the main reasons disabled of urban population.
Soft tissue injury refers to the damage of the motor system tissues such as skeletal muscle, fascia, ligament, joint capsule, periosteum, fatty tissue.Belong to motherland's medical science " injury of tendon and muscle " category, its morbidity extensively, is one of illness that orthopedics department is the most common, drastically influence the quality of people's productive life.
Chinese patent literature CN102861196A discloses a kind of Chinese medicine for the treatment of osteoarticular injury, is made up of by weight percentage following composition: Olibanum 10-35g, Myrrha 10-30g, Ramulus Cinnamomi 10-30g, Rhizoma Cimicifugae 5-35g, Radix Dipsaci 5-25g, Radix Et Rhizoma Rhei 5-20g, Stigma Croci 10-35g, brave amber 5-35g, Radix Angelicae Sinensis 5-30g, catechu 5-35g, company call 5-35g, Radix Notoginseng 10-35g, Herba Ephedrae 5-30g, Radix Angelicae Dahuricae 10-35g, eupolyphage sece steleophaga 10-40g, Sanguis Draxonis 8-25g, white giant 10-35g, Pyritum 10-35g together.Chinese patent literature CN200410004741.3 discloses the Chinese medicine composition that the invention discloses a kind of set a broken bone, soft tissue contusion's disease, and the crude drug such as the main Sanguis Draxonis of said composition, Realgar, Flos Carthami, catechu, Cinnabaris, Olibanum, Radix Angelicae Sinensis, Myrrha, Borneolum Syntheticum, Moschus, Pyritum, Eupolyphaga Seu Steleophaga, Rhizoma Drynariae, Radix Aconiti, Radix Notoginseng forms.Chinese patent literature CN104027691A discloses a kind of Chinese medicine decoction for the treatment of soft tissue injury, and the weight portion of its constitutive material is: Radix Angelicae Sinensis 6-10, Rhizoma Corydalis 5-8, Myrrha 4-6, Rhizoma Drynariae 6-8, Rhizoma Chuanxiong 3-5, Rhizoma Kaempferiae 4-7, Cortex Mori 3-6, eupolyphaga 2-3, Herba Lycopi 4-7, Radix Angelicae Dahuricae 5-7, Radix Scutellariae 2-3, Stigma Croci 3-5, Flos Caryophylli 6-8, eupolyphoge sinensis 2-3, RADIX CODONOPSIS PILOSULAE from Northwest of China 4-8, Rhizoma Corydalis 3-5, Fructus Aurantii 3-6, Herba Taraxaci 2-4, Borneolum Syntheticum 5-7, Radix berchemiae lineatae 4-6, Radix meliloti suaveolentis 3-7, Radix cynoglossi divaricati 5-8 and Bermuda grass 3-5.But yet there are no report about the Chinese medicine for the treatment of osteoarthrosis of the present invention and soft tissue injury and application thereof.
Summary of the invention
The object of the invention is for deficiency of the prior art, a kind of Chinese medicine for the treatment of osteoarthrosis and soft tissue injury is provided.
Of the present invention again one object be that a kind of application for the treatment of the Chinese medicine of osteoarthrosis and soft tissue injury is provided.
For achieving the above object, the technical scheme that the present invention takes is: a kind of Chinese medicine for the treatment of osteoarthrosis and soft tissue injury, described Chinese medicine is made primarily of the crude drug of following weight portion: Radix Clematidis 8-16 part, Rhizoma Drynariae 8-16 part, Caulis Piperis Kadsurae 8-16 part, Radix Curcumae 7-13 part, Herba Lycopodii 8-16 part, Radix Puerariae 7-13 part, Radix Dipsaci 7-13 part, Radix Cynanchi Paniculati 7-13 part, Herba Ephedrae 3-7 part, Radix Saposhnikoviae 7-13 part, Ramulus Cinnamomi 4-8 part, Herba Abri 7-13 part, Radix Trichosanthis 7-13 part, Semen Sinapis Albae 6-10 part, Flos Carthami 3-7 part, Cortex Phellodendri 7-13 part, Rhizoma Chuanxiong 4-8 part, Radix Angelicae Sinensis 8-16 part, Radix Rehmanniae 7-13 part.
Described Chinese medicine is made primarily of the crude drug of following weight portion: Radix Clematidis 10-14 part, Rhizoma Drynariae 10-14 part, Caulis Piperis Kadsurae 10-14 part, Radix Curcumae 8-12 part, Herba Lycopodii 10-14 part, Radix Puerariae 8-12 part, Radix Dipsaci 8-12 part, Radix Cynanchi Paniculati 8-12 part, Herba Ephedrae 4-6 part, Radix Saposhnikoviae 8-12 part, Ramulus Cinnamomi 5-7 part, Herba Abri 8-12 part, Radix Trichosanthis 8-12 part, Semen Sinapis Albae 7-9 part, Flos Carthami 4-6 part, Cortex Phellodendri 8-12 part, Rhizoma Chuanxiong 5-7 part, Radix Angelicae Sinensis 10-14 part, Radix Rehmanniae 8-12 part.
Described Chinese medicine is made primarily of the crude drug of following weight portion: Radix Clematidis 12 parts, Rhizoma Drynariae 12 parts, Caulis Piperis Kadsurae 12 parts, Radix Curcumae 10 parts, Herba Lycopodii 12 parts, Radix Puerariae 10 parts, Radix Dipsaci 10 parts, Radix Cynanchi Paniculati 10 parts, 5 parts, Herba Ephedrae, Radix Saposhnikoviae 10 parts, Ramulus Cinnamomi 6 parts, Herba Abri 10 parts, Radix Trichosanthis 10 parts, Semen Sinapis Albae 8 parts, 5 parts, Flos Carthami, Cortex Phellodendri 10 parts, Rhizoma Chuanxiong 6 parts, Radix Angelicae Sinensis 12 parts, 10 parts, the Radix Rehmanniae.
For realizing above-mentioned second object, the technical scheme that the present invention takes is: the application of described Chinese medicine in the medicine of preparation treatment osteoarticular injury.
The application of described Chinese medicine in the medicine of preparation treatment soft tissue injury.
Described pharmaceutical dosage form is tincture, spirit, powder, lotion, oil preparation, Emulsion, ointment, paste, plaster, liniment, gel, aerosol or Babu cream.
The invention has the advantages that:
Chinese medicine of the present invention has obvious reducing swelling and alleviating pain effect, and functional rehabilitation is fast, easy to use, meets Chinese medical theory, and clinical efficacy is remarkable, has no adverse reaction, should be widely promoted.
Detailed description of the invention
Below in conjunction with embodiment, detailed description of the invention provided by the invention is elaborated.
Treat a Chinese medicine for osteoarthrosis and soft tissue injury, described Chinese medicine is made primarily of the crude drug of following weight portion: Radix Clematidis 8-16 part, Rhizoma Drynariae 8-16 part, Caulis Piperis Kadsurae 8-16 part, Radix Curcumae 7-13 part, Herba Lycopodii 8-16 part, Radix Puerariae 7-13 part, Radix Dipsaci 7-13 part, Radix Cynanchi Paniculati 7-13 part, Herba Ephedrae 3-7 part, Radix Saposhnikoviae 7-13 part, Ramulus Cinnamomi 4-8 part, Herba Abri 7-13 part, Radix Trichosanthis 7-13 part, Semen Sinapis Albae 6-10 part, Flos Carthami 3-7 part, Cortex Phellodendri 7-13 part, Rhizoma Chuanxiong 4-8 part, Radix Angelicae Sinensis 8-16 part, Radix Rehmanniae 7-13 part.Preferably, Radix Clematidis 10-14 part, Rhizoma Drynariae 10-14 part, Caulis Piperis Kadsurae 10-14 part, Radix Curcumae 8-12 part, Herba Lycopodii 10-14 part, Radix Puerariae 8-12 part, Radix Dipsaci 8-12 part, Radix Cynanchi Paniculati 8-12 part, Herba Ephedrae 4-6 part, Radix Saposhnikoviae 8-12 part, Ramulus Cinnamomi 5-7 part, Herba Abri 8-12 part, Radix Trichosanthis 8-12 part, Semen Sinapis Albae 7-9 part, Flos Carthami 4-6 part, Cortex Phellodendri 8-12 part, Rhizoma Chuanxiong 5-7 part, Radix Angelicae Sinensis 10-14 part, Radix Rehmanniae 8-12 part.
Embodiment 1 Chinese medicine
Radix Clematidis 12 parts, Rhizoma Drynariae 12 parts, Caulis Piperis Kadsurae 12 parts, Radix Curcumae 10 parts, Herba Lycopodii 12 parts, Radix Puerariae 10 parts, Radix Dipsaci 10 parts, Radix Cynanchi Paniculati 10 parts, 5 parts, Herba Ephedrae, Radix Saposhnikoviae 10 parts, Ramulus Cinnamomi 6 parts, Herba Abri 10 parts, Radix Trichosanthis 10 parts, Semen Sinapis Albae 8 parts, 5 parts, Flos Carthami, Cortex Phellodendri 10 parts, Rhizoma Chuanxiong 6 parts, Radix Angelicae Sinensis 12 parts, 10 parts, the Radix Rehmanniae.
Embodiment 2 Chinese medicine
Radix Clematidis 10 parts, Rhizoma Drynariae 14 parts, Caulis Piperis Kadsurae 10 parts, Radix Curcumae 12 parts, Herba Lycopodii 10 parts, Radix Puerariae 12 parts, Radix Dipsaci 8 parts, Radix Cynanchi Paniculati 12 parts, 4 parts, Herba Ephedrae, Radix Saposhnikoviae 12 parts, Ramulus Cinnamomi 5 parts, Herba Abri 12 parts, Radix Trichosanthis 8 parts, Semen Sinapis Albae 9 parts, 4 parts, Flos Carthami, Cortex Phellodendri 12 parts, Rhizoma Chuanxiong 5 parts, Radix Angelicae Sinensis 14 parts, 8 parts, the Radix Rehmanniae.
Embodiment 3 Chinese medicine
Radix Clematidis 14 parts, Rhizoma Drynariae 10 parts, Caulis Piperis Kadsurae 14 parts, Radix Curcumae 8 parts, Herba Lycopodii 14 parts, Radix Puerariae 8 parts, Radix Dipsaci 12 parts, Radix Cynanchi Paniculati 8 parts, 6 parts, Herba Ephedrae, Radix Saposhnikoviae 8 parts, Ramulus Cinnamomi 7 parts, Herba Abri 8 parts, Radix Trichosanthis 12 parts, Semen Sinapis Albae 7 parts, 6 parts, Flos Carthami, Cortex Phellodendri 8 parts, Rhizoma Chuanxiong 7 parts, Radix Angelicae Sinensis 10 parts, 12 parts, the Radix Rehmanniae.
Embodiment 4 Chinese medicine
Radix Clematidis 8 parts, Rhizoma Drynariae 16 parts, Caulis Piperis Kadsurae 8 parts, Radix Curcumae 13 parts, Herba Lycopodii 8 parts, Radix Puerariae 13 parts, Radix Dipsaci 7 parts, Radix Cynanchi Paniculati 13 parts, 3 parts, Herba Ephedrae, Radix Saposhnikoviae 13 parts, Ramulus Cinnamomi 4 parts, Herba Abri 13 parts, Radix Trichosanthis 7 parts, Semen Sinapis Albae 10 parts, 3 parts, Flos Carthami, Cortex Phellodendri 13 parts, Rhizoma Chuanxiong 4 parts, Radix Angelicae Sinensis 16 parts, 7 parts, the Radix Rehmanniae.
Embodiment 5 Chinese medicine
Radix Clematidis 16 parts, Rhizoma Drynariae 8 parts, Caulis Piperis Kadsurae 16 parts, Radix Curcumae 7 parts, Herba Lycopodii 16 parts, Radix Puerariae 7 parts, Radix Dipsaci 13 parts, Radix Cynanchi Paniculati 7 parts, 7 parts, Herba Ephedrae, Radix Saposhnikoviae 7 parts, Ramulus Cinnamomi 8 parts, Herba Abri 7 parts, Radix Trichosanthis 13 parts, Semen Sinapis Albae 6 parts, 7 parts, Flos Carthami, Cortex Phellodendri 7 parts, Rhizoma Chuanxiong 8 parts, Radix Angelicae Sinensis 8 parts, 13 parts, the Radix Rehmanniae.
The preparation of embodiment 6 Chinese medicine
The pharmaceutical dosage form that the arbitrary described Chinese medicine of embodiment 1-5 is prepared by conventional formulation means, such as tincture, spirit, powder, lotion, oil preparation, Emulsion, ointment, paste, plaster, liniment, gel, aerosol or Babu cream etc.
Embodiment 7 clinical trial
1 clinical data
1.1 object of study
Osteoarthrosis and soft tissue injury patient, from Changhai hospital door emergency treatment, formulate diagnostic criteria and treatment standard according to " Chinese traumatology ".
1.2 primary symptom criterions
Pain: slight, has pain perception, does not affect routine work with movable; Moderate, the swollen sensation of pain acid, can adhere to routine work and life; Severe, sharp ache, is difficult to stand, and affects routine work and life.Swelling: slight, the colour of skin changes, and swelling degree is higher than normal skin 1mm-3mm; Moderate, the colour of skin changes, and swelling degree is higher than between normal skin 4mm ~ 6mm; Severe, the colour of skin changes, smooth bright or livid purple visible.Swelling degree is higher than normal skin 5mm-10mm.Functional activity scope: good (+), in more than 1/2 of normal range; In (++), between 1/2 ~ 1/3 of normal range; Difference (+++), in less than 1/3 of normal range.
1.3 grouping
Observe osteoarticular injury patient 50 example, soft tissue injury patient 50 example altogether, study subject is divided into two groups at random, matched group 50 example (osteoarticular injury, each 25 examples of soft tissue injury), treatment group 50 example (osteoarticular injury, each 25 examples of soft tissue injury), the not statistically significant difference (P > 0.05) such as age, sex, the course of disease, symptom of matched group and treatment group, has comparability.
1.4 Therapeutic Method
Matched group: plaster treatment affected part, Zhenjiang, every day 1 time 2 weeks is a course for the treatment of.
Treatment group: the Chinese medicine of embodiment 1, hot compress or washout affected part, every day each 1 time sooner or later 2 weeks is a course for the treatment of.
2. efficacy analysis
2.1 criterion of therapeutical effect
Recovery from illness: 1 course for the treatment of of the drug of topical application, pain, swelling disappear, and movable function scope is normal; Effective: 1 course for the treatment of of the drug of topical application, pain, swelling obviously alleviate or disappear, and movable function scope is transferred to (+) by (+++); Effective: 1 course for the treatment of of the drug of topical application, pain, swelling alleviate, and movable function scope is transferred to (++) by (+++); Invalid: 1 course for the treatment of of the drug of topical application, local symptom is without improvement.
2.2 therapeutic outcome
After treatment, the patients symptomatic of matched group and treatment group all makes moderate progress relative to before treatment, P < 0.05; The curative effect for the treatment of group is obviously better than matched group, P < 0.05.Concrete outcome is as shown in table 1, table 2, table 3.
The comparison of average onset time after table 1 liang group medication
The comparison of table 2 liang group transference cure time
The comparison of table 3 liang group overall patient curative effect
The above is only the preferred embodiment of the present invention; it should be pointed out that for those skilled in the art, under the prerequisite not departing from the inventive method; can also make some improvement and supplement, these improve and supplement and also should be considered as protection scope of the present invention.
Claims (6)
1. treat the Chinese medicine of osteoarthrosis and soft tissue injury for one kind, it is characterized in that, described Chinese medicine is made primarily of the crude drug of following weight portion: Radix Clematidis 8-16 part, Rhizoma Drynariae 8-16 part, Caulis Piperis Kadsurae 8-16 part, Radix Curcumae 7-13 part, Herba Lycopodii 8-16 part, Radix Puerariae 7-13 part, Radix Dipsaci 7-13 part, Radix Cynanchi Paniculati 7-13 part, Herba Ephedrae 3-7 part, Radix Saposhnikoviae 7-13 part, Ramulus Cinnamomi 4-8 part, Herba Abri 7-13 part, Radix Trichosanthis 7-13 part, Semen Sinapis Albae 6-10 part, Flos Carthami 3-7 part, Cortex Phellodendri 7-13 part, Rhizoma Chuanxiong 4-8 part, Radix Angelicae Sinensis 8-16 part, Radix Rehmanniae 7-13 part.
2. Chinese medicine according to claim 1, it is characterized in that, described Chinese medicine is made primarily of the crude drug of following weight portion: Radix Clematidis 10-14 part, Rhizoma Drynariae 10-14 part, Caulis Piperis Kadsurae 10-14 part, Radix Curcumae 8-12 part, Herba Lycopodii 10-14 part, Radix Puerariae 8-12 part, Radix Dipsaci 8-12 part, Radix Cynanchi Paniculati 8-12 part, Herba Ephedrae 4-6 part, Radix Saposhnikoviae 8-12 part, Ramulus Cinnamomi 5-7 part, Herba Abri 8-12 part, Radix Trichosanthis 8-12 part, Semen Sinapis Albae 7-9 part, Flos Carthami 4-6 part, Cortex Phellodendri 8-12 part, Rhizoma Chuanxiong 5-7 part, Radix Angelicae Sinensis 10-14 part, Radix Rehmanniae 8-12 part.
3. Chinese medicine according to claim 1, it is characterized in that, described Chinese medicine is made primarily of the crude drug of following weight portion: Radix Clematidis 12 parts, Rhizoma Drynariae 12 parts, Caulis Piperis Kadsurae 12 parts, Radix Curcumae 10 parts, Herba Lycopodii 12 parts, Radix Puerariae 10 parts, Radix Dipsaci 10 parts, Radix Cynanchi Paniculati 10 parts, 5 parts, Herba Ephedrae, Radix Saposhnikoviae 10 parts, Ramulus Cinnamomi 6 parts, Herba Abri 10 parts, Radix Trichosanthis 10 parts, Semen Sinapis Albae 8 parts, 5 parts, Flos Carthami, Cortex Phellodendri 10 parts, Rhizoma Chuanxiong 6 parts, Radix Angelicae Sinensis 12 parts, 10 parts, the Radix Rehmanniae.
4. according to the application of the arbitrary described Chinese medicine of claim 1-3 in the medicine of preparation treatment osteoarticular injury.
5. according to the application of the arbitrary described Chinese medicine of claim 1-3 in the medicine of preparation treatment soft tissue injury.
6., according to the arbitrary described application of claim 4 or 5, it is characterized in that, described pharmaceutical dosage form is tincture, spirit, powder, lotion, oil preparation, Emulsion, ointment, paste, plaster, liniment, gel, aerosol or Babu cream.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510003740.5A CN104491745B (en) | 2015-01-06 | 2015-01-06 | A kind of Chinese medicine for treating Bones and joints and soft tissue injury and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510003740.5A CN104491745B (en) | 2015-01-06 | 2015-01-06 | A kind of Chinese medicine for treating Bones and joints and soft tissue injury and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104491745A true CN104491745A (en) | 2015-04-08 |
CN104491745B CN104491745B (en) | 2018-02-13 |
Family
ID=52933259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510003740.5A Expired - Fee Related CN104491745B (en) | 2015-01-06 | 2015-01-06 | A kind of Chinese medicine for treating Bones and joints and soft tissue injury and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491745B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194205A (en) * | 2015-10-19 | 2015-12-30 | 廖国生 | Chinese herbal medicine composition for treating fracture and joint soft tissue injury |
-
2015
- 2015-01-06 CN CN201510003740.5A patent/CN104491745B/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
姚共和等: "中医期刊治疗膝关节骨关节炎方剂用药特点分析", 《湖南中医学院学报》 * |
汪悦: "《风湿病中医治疗》", 31 May 2005, 江苏科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194205A (en) * | 2015-10-19 | 2015-12-30 | 廖国生 | Chinese herbal medicine composition for treating fracture and joint soft tissue injury |
Also Published As
Publication number | Publication date |
---|---|
CN104491745B (en) | 2018-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103961636B (en) | Orthopedic disease treatment external application traditional Chinese medicine composition, preparation method and application thereof | |
CN104784270A (en) | External preparation capable of relieving swelling and pain and preparation method thereof | |
CN104288228A (en) | Traditional Chinese medicine composite for treating pain in neck, shoulders, waist and legs | |
CN101244241A (en) | Cunt shrinking and maintaining agent for gynaecologic treatment | |
DK201600379A1 (en) | Detumescence Odynolysis Ointment | |
CN103566278B (en) | Cortex torricelliae tiliifoliae | |
CN101085222A (en) | Plaster for relieving pain | |
CN102727856B (en) | Volatile oil for treating arthralgia and injuries of tendons and preparation method of volatile oil | |
CN104491745A (en) | Traditional Chinese medicine for treating injury of osteoarticular and soft tissue and application of traditional Chinese medicine | |
CN102145149B (en) | Plaster for treating arthralgia and myalgia | |
CN112121086A (en) | A Chinese medicinal tincture for transdermal therapy and its preparation method | |
CN102526405B (en) | Chinese medicinal composition for accelerating fracture healing | |
CN105687798A (en) | External traditional Chinese medicinal preparation for treating stroke and preparation method of external traditional Chinese medicinal preparation | |
CN105079206A (en) | Pain relieving traditional Chinese medicine composition and preparation method thereof | |
CN104547619A (en) | Traditional Chinese medicine for treating apoplexy sequela paralytic limbs and preparation method of traditional Chinese medicine | |
CN101361955B (en) | Traditional Chinese medicine combination for treating rheumatism | |
CN105194317A (en) | Traditional Chinese medicine composition for treating bone joint injuries and application of traditional Chinese medicine composition | |
CN102614341B (en) | Chinese medicinal composition for promoting fracture healing | |
CN105688170A (en) | External traditional Chinese medicinal composition for treating stroke, preparation of external traditional Chinese medicinal composition and preparation method of external traditional Chinese medicinal composition | |
CN101322831B (en) | Chinese medicine powder for treating hydrohystera of milk cattle and preparation method thereof | |
CN105232977A (en) | External use medicine for treating gynecologic inflammation | |
CN104740565A (en) | Traditional Chinese medicine composition for treating cold injury | |
CN105106882A (en) | Traditional Chinese medicine composition for treating frostbite | |
CN104383027A (en) | Chinese medicinal ointment with efficacies of promoting tissue regeneration and setting broken bone and preparation method thereof | |
CN103690748B (en) | A kind of deep essence of the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) for the treatment of hyperosteogeny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180213 Termination date: 20190106 |